A regulation included in the US Food and Drug Administration’s cosmetics program overhaul to standardize and require testing for asbestos in talc-containing products should eliminate guesswork for manufacturers while also giving the plaintiffs’ bar a more stationary target.
The FDA is required by 29 December under the Modernization of Cosmetics Regulation Act (MOCRA) to issue a proposed regulation...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?